相似文献
1
Exercise Hemodynamics in Heart Failure with Preserved Ejection Fraction.
Heart Fail Clin. 2025 Jan;21(1):27-34. doi: 10.1016/j.hfc.2024.08.003. Epub 2024 Sep 30.
2
Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic Analysis.
JACC Heart Fail. 2019 Mar;7(3):239-249. doi: 10.1016/j.jchf.2019.01.004.
3
Relative Impairments in Hemodynamic Exercise Reserve Parameters in Heart Failure With Preserved Ejection Fraction: A Study-Level Pooled Analysis.
JACC Heart Fail. 2018 Feb;6(2):117-126. doi: 10.1016/j.jchf.2017.10.014.
4
Post-exercise left atrial conduit strain predicted hemodynamic change in heart failure with preserved ejection fraction.
Eur Radiol. 2024 Mar;34(3):1825-1835. doi: 10.1007/s00330-023-10142-z. Epub 2023 Aug 31.
5
Current Limitations of Invasive Exercise Hemodynamics for the Diagnosis of Heart Failure With Preserved Ejection Fraction.
Circ Heart Fail. 2021 May;14(5):e007555. doi: 10.1161/CIRCHEARTFAILURE.120.007555. Epub 2021 May 6.
6
Exercise Intolerance in Heart Failure with Preserved Ejection Fraction.
Heart Fail Clin. 2021 Jul;17(3):397-413. doi: 10.1016/j.hfc.2021.03.004.
7
Simultaneous Measurement of Lung Diffusing Capacity and Pulmonary Hemodynamics Reveals Exertional Alveolar-Capillary Dysfunction in Heart Failure With Preserved Ejection Fraction.
J Am Heart Assoc. 2021 Aug 17;10(16):e019950. doi: 10.1161/JAHA.120.019950. Epub 2021 Aug 7.
8
Impaired left atrial strain predicts abnormal exercise haemodynamics in heart failure with preserved ejection fraction.
Eur J Heart Fail. 2019 Apr;21(4):495-505. doi: 10.1002/ejhf.1399. Epub 2019 Jan 16.
9
Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients With Preserved Ejection Fraction.
JACC Heart Fail. 2019 Apr;7(4):321-332. doi: 10.1016/j.jchf.2019.01.006. Epub 2019 Mar 6.
10
Pulmonary Vascular Resistance During Exercise Predicts Long-Term Outcomes in Heart Failure With Preserved Ejection Fraction.
J Card Fail. 2018 Mar;24(3):169-176. doi: 10.1016/j.cardfail.2017.11.003. Epub 2017 Nov 24.
本文引用的文献
1
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.
N Engl J Med. 2023 Sep 21;389(12):1069-1084. doi: 10.1056/NEJMoa2306963. Epub 2023 Aug 25.
2
Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial.
Circulation. 2023 Sep 5;148(10):834-844. doi: 10.1161/CIRCULATIONAHA.123.065134. Epub 2023 Aug 3.
3
Challenging the Hemodynamic Hypothesis in Heart Failure With Preserved Ejection Fraction: Is Exercise Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure?
Circulation. 2023 Jan 31;147(5):378-387. doi: 10.1161/CIRCULATIONAHA.122.061828. Epub 2022 Dec 16.
4
Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea.
JAMA Cardiol. 2022 Sep 1;7(9):891-899. doi: 10.1001/jamacardio.2022.1916.
5
Impact of Esophageal Pressure Measurement on Pulmonary Hypertension Diagnosis in Patients With Obesity.
Chest. 2022 Sep;162(3):684-692. doi: 10.1016/j.chest.2022.04.002. Epub 2022 Apr 9.
6
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
N Engl J Med. 2021 Oct 14;385(16):1451-1461. doi: 10.1056/NEJMoa2107038. Epub 2021 Aug 27.
7
Current Limitations of Invasive Exercise Hemodynamics for the Diagnosis of Heart Failure With Preserved Ejection Fraction.
Circ Heart Fail. 2021 May;14(5):e007555. doi: 10.1161/CIRCHEARTFAILURE.120.007555. Epub 2021 May 6.
8
Impact of severe obesity on exercise performance in heart failure with preserved ejection fraction.
Physiol Rep. 2020 Nov;8(22):e14634. doi: 10.14814/phy2.14634.
9
Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation.
J Am Coll Cardiol. 2020 Sep 1;76(9):1051-1064. doi: 10.1016/j.jacc.2020.07.009.
10
Atrial Myopathy.
JACC Basic Transl Sci. 2019 Sep 23;4(5):640-654. doi: 10.1016/j.jacbts.2019.05.005. eCollection 2019 Sep.
Zotero 插件